Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Gross Profit: 2016-2024

Historic Gross Profit for Crinetics Pharmaceuticals (CRNX) over the last 9 years, with Dec 2024 value amounting to $1.0 million.

  • Crinetics Pharmaceuticals' Gross Profit was N/A to $143,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2024, which is 74.11% down from last year.
  • According to the latest figures from FY2024, Crinetics Pharmaceuticals' Gross Profit is $1.0 million, which was down 74.11% from $4.0 million recorded in FY2023.
  • Crinetics Pharmaceuticals' Gross Profit's 5-year high stood at $4.7 million during FY2022, with a 5-year trough of $71,000 in FY2020.
  • In the last 3 years, Crinetics Pharmaceuticals' Gross Profit had a median value of $4.0 million in 2023 and averaged $3.3 million.
  • As far as peak fluctuations go, Crinetics Pharmaceuticals' Gross Profit slumped by 94.05% in 2020, and later skyrocketed by 1,418.31% in 2021.
  • Over the past 5 years, Crinetics Pharmaceuticals' Gross Profit (Yearly) stood at $71,000 in 2020, then spiked by 1,418.31% to $1.1 million in 2021, then skyrocketed by 339.42% to $4.7 million in 2022, then decreased by 15.28% to $4.0 million in 2023, then tumbled by 74.11% to $1.0 million in 2024.